SMCs With LVH Compared to HCM

National Center for Cardiovascular Diseases

Status: Active, not recruiting

Conditions: Syndromic and Metabolic Cardiomyopathy; Cardiomyopathies

Treatments: Other: SMCs

Study type: Observational

Funder types: Other

Identifiers

NCT07006974

2021-ZDYF-01-4

Details and patient eligibility

About

The goal of this cohort study is to investigate the clinical characteristics of SMCs and to explore the difference in cardiovascular outcomes in comparison to age-, sex-, and admission year-matched HCM patients. The main question it aims to answer is:

• Do patients with SMCs have higher rates of cardiac outcomes?
• What risk factors do SMCs patients experience a poor prognosis?

Enrollment: 165 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients who were diagnosed SMCs or HCM. Gene testing and muscle biopsy were used to confirm the diagnosis of SMCs. The diagnose of HCM was according to the 2024 ESC Guidelines of HCM but without evidence of SMCs.
• complete baseline data
• accessible follow-up data

Exclusion criteria

• incomplete baseine data